Panting Michael, Holme Inger B, Dionisio Giuseppe, Brinch-Pedersen Henrik
Department of Agroecology - Crop Genetics and Biotechnology, Aarhus University, Slagelse, Denmark.
Plant Biotechnol J. 2025 Jun;23(6):2418-2428. doi: 10.1111/pbi.70065. Epub 2025 Mar 27.
Anti-nutritional factors in plant seeds diminish the utilization of nutrients in feed and food. Among these, protease inhibitors inhibit protein degradation by exogenous proteases during digestion. Through conventional and selection-gene-free genome editing using ovules as explants, we used simplex and multiplex CRISPR/Cas9 for studying the impact of chymotrypsin inhibitor CI-1A, CI-1B and CI-2, Bowman-Birk trypsin inhibitor, Serpin-Z4, and barley ɑ-amylase/subtilisin inhibitor on barley and soybean storage protein degradation. Mutants were generated in the commercial cultivar Stairway, having a high level of protease inhibition, and the barley model cultivar Golden Promise, having a lower inhibition level. In Golden Promise, all individual knockouts decreased the inhibition of the three proteases α-chymotrypsin, trypsin and the commercial feed protease Ronozyme ProAct significantly. The triple knockout of all chymotrypsin inhibitors further decreased the inhibition of α-chymotrypsin and Ronozyme ProAct proteases. Degradations of recombinant barley storage proteins B- and C-hordeins were significantly improved following mutagenesis. In Stairway, a single knockout of CI-1A almost compares to the effect on the proteases achieved for the triple knockout in Golden promise, uncovering CI-1A as the major protease inhibitor in that cultivar. The Stairway mutant demonstrated significantly improved degradation of recombinant barley hordeins and in the soybean storage proteins glycinin and β-conglycinin. The results of this study provide insights into cereal protease inhibitor genes and their negative effects on the degradation of barley storage protein and the most important plant protein from soybeans. The study suggests a future focus on plant protease inhibitors as a major target for improving feed and food protein digestibility.
植物种子中的抗营养因子会降低饲料和食物中营养物质的利用率。其中,蛋白酶抑制剂会抑制消化过程中外源蛋白酶对蛋白质的降解。通过以胚珠为外植体的常规和无选择基因的基因组编辑,我们使用单重和多重CRISPR/Cas9研究了胰凝乳蛋白酶抑制剂CI-1A、CI-1B和CI-2、鲍曼-伯克胰蛋白酶抑制剂、丝氨酸蛋白酶抑制剂Z4以及大麦α-淀粉酶/枯草杆菌蛋白酶抑制剂对大麦和大豆储存蛋白降解的影响。在蛋白酶抑制水平较高的商业品种“阶梯”和抑制水平较低的大麦模式品种“金色承诺”中产生了突变体。在“金色承诺”中,所有单个基因敲除均显著降低了对三种蛋白酶α-胰凝乳蛋白酶、胰蛋白酶和商业饲料蛋白酶诺维信ProAct的抑制作用。所有胰凝乳蛋白酶抑制剂的三重基因敲除进一步降低了对α-胰凝乳蛋白酶和诺维信ProAct蛋白酶的抑制作用。诱变后,重组大麦储存蛋白B-和C-醇溶蛋白的降解得到显著改善。在“阶梯”中,CI-1A的单个基因敲除几乎与“金色承诺”中三重基因敲除对蛋白酶的影响相当,表明CI-1A是该品种中的主要蛋白酶抑制剂。“阶梯”突变体显示重组大麦醇溶蛋白以及大豆储存蛋白大豆球蛋白和β-伴大豆球蛋白的降解显著改善。本研究结果为谷物蛋白酶抑制剂基因及其对大麦储存蛋白和大豆最重要的植物蛋白降解的负面影响提供了见解。该研究表明,未来应将植物蛋白酶抑制剂作为提高饲料和食物蛋白质消化率的主要靶点。